RHHBYRoche Holdings Ltd ADR

$37.44
$-0.12 (0%)

Create a FREE Account to View Full Report

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.
Analyst ForecastNext 12 months ➝Current Price$37.4452-week High$37.7952-week Low$29.45No Forecast Data Available for RHHBY
  • Last Price$37.44
  • Previous Close$37.56
  • Change $-0.12
  • Open$37.34
  • Volume351,950
  • Avg. Volume (100-day)1,318,717
  • Market Capitalization$256.41B
  • Days Range $37.34 - $37.55
  • 52-week Range $29.45 - $37.79
  • Dividend Yield1.81%
  • Ex. Dividend Date03/07/2019
  • P-E21.4
  • EPS1.55
  • Earnings Date
  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • Avg. Analyst Rec.
  • Beta0.662
  • PEG Ratio
  • Volatility0.12
  • Average True Range0.01